Search Results - "Hohlfeld, J. M."

Refine Results
  1. 1
  2. 2

    Safety, efficacy and repeatability of a novel house dust mite allergen challenge technique in the Fraunhofer allergen challenge chamber by Lueer, K., Biller, H., Casper, A., Windt, H., Mueller, M., Badorrek, P., Haefner, D., Framke, T., Koch, A., Ziehr, H., Krug, N., Koch, W., Hohlfeld, J. M.

    Published in Allergy (Copenhagen) (01-12-2016)
    “…Background Efficacy testing of immunotherapy in field studies is often hampered by variation of airborne allergens. Standardized allergen exposure in challenge…”
    Get full text
    Journal Article
  3. 3

    Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions by Hohlfeld, J. M., Holland-Letz, T., Larbig, M., Lavae-Mokhtari, M., Wierenga, E., Kapsenberg, M., Van Ree, R., Krug, N., Bufe, A.

    Published in Clinical and experimental allergy (01-07-2010)
    “…Summary Background Efficacy testing of drugs in seasonal allergic rhinitis (SAR) is often disturbed by seasonal variations of environmental allergens, and…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease by Hohlfeld, J.M., Sharma, A., van Noord, J.A., Cornelissen, P.J.G., Derom, E., Towse, L., Peterkin, V., Disse, B.

    Published in Journal of clinical pharmacology (01-04-2014)
    “…The aim of the study was to characterize pharmacokinetics of tiotropium solution 5 µg compared to powder 18 µg and assess dose‐dependency of tiotropium…”
    Get full text
    Journal Article
  5. 5

    Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices by Switalla, S., Lauenstein, L., Prenzler, F., Knothe, S., Förster, C., Fieguth, H.-G., Pfennig, O., Schaumann, F., Martin, C., Guzman, C.A., Ebensen, T., Müller, M., Hohlfeld, J.M., Krug, N., Braun, A., Sewald, K.

    Published in Toxicology and applied pharmacology (01-08-2010)
    “…Prediction of lung innate immune responses is critical for developing new drugs. Well-established immune modulators like lipopolysaccharides (LPS) can elicit a…”
    Get full text
    Journal Article
  6. 6

    Allergen Challenge Increases Anandamide in Bronchoalveolar Fluid of Patients With Allergic Asthma by Zoerner, A A, Stichtenoth, D O, Engeli, S, Batkai, S, Winkler, C, Schaumann, F, Janke, J, Holz, O, Krug, N, Tsikas, D, Jordan, J, Hohlfeld, J M

    Published in Clinical pharmacology and therapeutics (01-09-2011)
    “…Preclinical studies suggest that the endocannabinoid anandamide restrains allergic airway obstruction and inflammation. Therefore, we applied saline or…”
    Get full text
    Journal Article
  7. 7

    Efficacy and safety of inhaled calcium lactate PUR118 in the ozone challenge model--a clinical trial by Holz, Olaf, Biller, H, Mueller, M, Kane, K, Rosano, M, Hanrahan, J, Hava, D L, Hohlfeld, J M

    Published in BMC pharmacology & toxicology (12-08-2015)
    “…The ozone challenge model can be used to assess the efficacy of anti-inflammatory compounds in early phases of clinical drug development. PUR118, a calcium…”
    Get full text
    Journal Article
  8. 8

    Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis by Krug, N., Loedding, H., Hohlfeld, J. M., Larbig, M., Buckendahl, A., Badorrek, P., Geldmacher, H., Behnke, W., Dunkhorst, W., Windt, H., Luettig, B., Koch, W.

    Published in Clinical and experimental allergy (01-12-2003)
    “…Summary Background There is an increasing need for allergen inhalation systems to perform basic clinical research and test anti‐allergic drugs under…”
    Get full text
    Journal Article
  9. 9

    Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice by Erpenbeck, V. J., Ziegert, M., Cavalet-Blanco, D., Martin, C., Baelder, R., Glaab, T., Braun, A., Steinhilber, W., Luettig, B., Uhlig, S., Hoymann, H. G., Krug, N., Hohlfeld, J. M.

    Published in Clinical and experimental allergy (01-07-2006)
    “…Summary Background The surfactant protein SP‐D has been reported to reduce bronchial hyper‐responsiveness, blood eosinophilia, and T‐helper type 2 cytokines in…”
    Get full text
    Journal Article
  10. 10

    Surfactant protein levels in bronchoalveolar lavage after segmental allergen challenge in patients with asthma by Erpenbeck, V. J., Schmidt, R., Günther, A., Krug, N., Hohlfeld, J. M.

    Published in Allergy (Copenhagen) (01-05-2006)
    “…Background:  Allergic asthma is associated with airway inflammation and dysfunction of pulmonary surfactant. Because surfactant proteins (SP) account for…”
    Get full text
    Journal Article
  11. 11

    Rating sputum cell quality in clinical trials for asthma and COPD treatment by Pedersen, Frauke, Zissler, Ulrich M, Watz, Henrik, Rabe, Klaus F, Hohlfeld, Jens M, Holz, Olaf

    “…Background Induced sputum is a method to assess airway inflammation in clinical trials for asthma and COPD.1–3 Sputum is a heterogeneous, viscous material…”
    Get full text
    Journal Article
  12. 12

    Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit by Krug, N., Hohlfeld, J. M., Geldmacher, H., Larbig, M., Heermann, R., LaVallee, N., Nguyen, D. T., Petzold, U., Hermann, R.

    Published in Allergy (Copenhagen) (01-03-2005)
    “…Background:  Loteprednol etabonate (LE) is a novel soft steroid that was designed to improve the benefit/risk ratio of topical corticosteroid therapy. This…”
    Get full text
    Journal Article
  13. 13

    Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension by HOEPER, M. M, MAIER, R, TONGERS, J, NIEDERMEYER, J, HOHLFELD, J. M, HAMM, M, FABEL, H

    “…Assessment of cardiac output is an important part of the management of patients with pulmonary hypertension. The accuracy of the thermodilution technique in…”
    Get full text
    Journal Article
  14. 14

    Lung fibroblasts from patients with emphysema show markers of senescence in vitro by Müller, K-C, Welker, L, Paasch, K, Feindt, B, Erpenbeck, V J, Hohlfeld, J M, Krug, N, Nakashima, M, Branscheid, D, Magnussen, H, Jörres, R A, Holz, O

    Published in Respiratory research (21-02-2006)
    “…The loss of alveolar walls is a hallmark of emphysema. As fibroblasts play an important role in the maintenance of alveolar structure, a change in fibroblast…”
    Get full text
    Journal Article
  15. 15

    Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts by Sadovski, J, Kuchenbuch, T, Ruppert, C, Fehrenbach, A, Hirschburger, M, Padberg, W, Gunther, A, Hohlfeld, J. M, Fehrenbach, H, Grau, V

    Published in The European respiratory journal (01-01-2008)
    “…Primary graft dysfunction, characterised by intra-alveolar oedema, is a major obstacle in pulmonary transplantation. The present study evaluates the potential…”
    Get full text
    Journal Article
  16. 16

    Left heart function in COPD: Impact of lung deflation by Struß, N., Bauersachs, J., Welte, T., Hohlfeld, J. M.

    Published in Herz (01-09-2019)
    “…Chronic obstructive pulmonary disease (COPD) primarily affects the lungs; however, cardiovascular conditions are among the most common extrapulmonary…”
    Get full text
    Journal Article
  17. 17

    Hyperuricaemia in patients with right or left heart failure by Hoeper, MM, Hohlfeld, JM, Fabel, H

    Published in The European respiratory journal (01-03-1999)
    “…Based on the clinical observation that patients with right or left heart failure often present with hyperuricaemia, the relation between serum urate values and…”
    Get full text
    Journal Article
  18. 18

    Effect of anti‐nerve growth factor on early and late airway responses in allergic rats by Glaab, T., Hoymann, H. G., Hecht, M., Korolewitz, R., Tschernig, T., Hohlfeld, J. M., Krug, N., Braun, A.

    Published in Allergy (Copenhagen) (01-09-2003)
    “…Background: The increased production of nerve growth factor (NGF) has been associated with allergen‐induced airway hyperresponsiveness and enhanced airway…”
    Get full text
    Journal Article
  19. 19

    A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD by Gaida, A, Holz, O, Nell, C, Schuchardt, S, Lavae-Mokhtari, B, Kruse, L, Boas, U, Langejuergen, J, Allers, M, Zimmermann, S, Vogelmeier, C, Koczulla, A R, Hohlfeld, J M

    Published in Journal of breath research (15-04-2016)
    “…There is increasing evidence that breath volatile organic compounds (VOC) have the potential to support the diagnosis and management of inflammatory diseases…”
    Get more information
    Journal Article
  20. 20

    Measurement of exhaled volatile organic compounds from patients with chronic obstructive pulmonary disease (COPD) using closed gas loop GC-IMS and GC-APCI-MS by Allers, M, Langejuergen, J, Gaida, A, Holz, O, Schuchardt, S, Hohlfeld, J M, Zimmermann, S

    Published in Journal of breath research (08-04-2016)
    “…Due to its high sensitivity, compact size and low cost ion mobility spectrometry (IMS) has the potential to become a point-of-care breath analyzer. Therefore,…”
    Get more information
    Journal Article